Usefulness of Pindolol for treatment of neurocardiogenic syncope

Nandini Nair, Farooq A. Padder, Steven P. Kutalek, Bharat K. Kantharia

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


This study evaluated the efficacy of pindolol, a noncardioselective β blocker with intrinsic sympathetic activity, on neurocardiogenic syncope using a head-up tilt-table test in 66 patients. Pindolol was equally effective in men and women and the 2 age groups (>60 and <60 years) of the study cohort. The earliest benefit was seen ≤3 days after initiating treatment. Side effects were better tolerated in younger patients (age <60 years).

Original languageEnglish (US)
Pages (from-to)1189-1191
Number of pages3
JournalAmerican Journal of Cardiology
Issue number9
StatePublished - Nov 1 2004

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Usefulness of Pindolol for treatment of neurocardiogenic syncope'. Together they form a unique fingerprint.

Cite this